Wealth Alliance Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Wealth Alliance Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,913	Closed	-$218K	–	167
2021 Q3	$218K	Hold	2,913	–	–	0.11%	133
2021 Q2	$269K	Hold	2,913	–	–	0.13%	116
2021 Q1	$258K	Sell	2,913 -463	-14%	-$45.9K	0.13%	119
2020 Q4	$315K	Sell	3,376 -169	-5%	-$13.5K	0.17%	96
2020 Q3	$226K	Buy	+3,545	New	+$208K	0.13%	111
2018 Q4	–	Sell	-7,700	Closed	-$257K	–	119
2018 Q3	$257K	Hold	7,700	–	–	0.13%	112
2018 Q2	$224K	Buy	+7,700	New	+$214K	0.12%	112

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wealth Alliance Advisory Group's ARKG Position: Q4 2021 in Review

Wealth Alliance Advisory Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 2,913 shares — an estimated $218K sold.

Wealth Alliance Advisory Group first reported a position in ARKG in Q2 2018 and held it in 7 quarters. The position peaked at $315K in Q4 2020. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

Wealth Alliance Advisory Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
Wealth Alliance Advisory Group sold 2,913 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $218K.
Wealth Alliance Advisory Group first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 7 quarters.
Wealth Alliance Advisory Group's ARK Genomic Revolution ETF position peaked at $315K in Q4 2020.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Wealth Alliance Advisory Group's 13F filing for Q4 2021, filed 13 Jan 2022.